Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

DXCM

+ Watchlist+ Portfolio

DexCom, Inc.

Regulated industryPhysical productsTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$82.52
52-Week Range
$56.72 – $92.59
Market Cap
$29.91B
P/E (TTM)
31.57
EPS (TTM)
2.54
Dividend Yield
0.00%
Advanced Metrics
Price/Book
11.80
PEG Ratio
1.30
Return on Equity
37.67%
Return on Assets
11.13%
Gross Margin
63.42%
Operating Margin
23.97%
Profit Margin
19.42%
Current Ratio
1.74
Debt/Equity
0.55
Total Debt
$1.39B
Free Cash Flow
$811.90M
Revenue Growth
11.20%
Earnings Growth
2.60%
Enterprise Value
$30.35B

Market Snapshot

About

DexCom, Inc. is a medical device company that designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes. The company's flagship products, including the Dexcom G6 and G7 systems, provide real-time glucose readings without the need for fingerstick calibration. DexCom's CGM technology uses a small sensor inserted under the skin that transmits glucose data wirelessly to a receiver or smartphone app. The company's systems help patients manage their diabetes more effectively and reduce the risk of dangerous blood sugar fluctuations. DexCom serves both Type 1 and Type 2 diabetes patients and has partnerships with insulin pump manufacturers for integrated diabetes management systems.